Meeting Objectives: Recognize patients with high-risk cSCC early in the treatment pathway who may be appropriate candidates for adjuvant therapy using current evidence and risk stratification criteria. Enhance multidisciplinary communication and referral strategies to engage pharmacists earlier in the treatment...






